MMIS President and CEO Michaeline Daboul at the 5th Annual Corporate Compliance & Transparency in the Pharmaceutical Industry Fleming Conference

New EU Data Protection rules to be highlighted at conference ZURICH, Switzerland (Feb. 22, 2017) – MMIS, Inc., a leading provider of global compliance solutions for life sciences, today announced that Michaeline Daboul, CEO and co-founder, will speak at the 5th Annual Corporate Compliance & Transparency in the Pharmaceutical Industry Fleming Conference in Zurich on […]

0 comments

MMIS President and CEO Michaeline Daboul to Speak at the 3rd Annual Global Compliance Congress for Life Sciences

Global Compliance Remains a Focus for Life Science Companies as Britain Negotiates Its Exit from the European Union Portsmouth, NH, November 2, 2016– MMIS President and CEO Michaeline Daboul will be speaking at the CBI 3rd Annual Global Compliance Congress for Life Sciences, in London on November 16-17. “As Brexit continues, pharmaceutical and medical device companies […]

0 comments

MMIS President and CEO Michaeline Daboul to Speak at 17th Annual Pharmaceutical and Medical Device Compliance Congress

Leveraging Enterprise Analytics for Compliance Monitoring Portsmouth, NH, October 13, 2016 – MMIS, creator of the award winning MediSpend Global Compliance Platform, announced today that President and CEO Michaeline Daboul will join legal and compliance experts at the 17th Annual Pharmaceutical and Medical Device Compliance Congress to be held on October 19-21, 2016 in Washington, DC.  Ms. Daboul […]

0 comments

MMIS President and CEO Michaeline Daboul to speak at 4th Annual Pharma Compliance Europe Conference

New Standards for Enterprise Compliance Management London, October 4, 2016 – MMIS President and CEO, Michaeline Daboul, will join legal and compliance professionals at Pharma Compliance Europe 2016 October 5-6, 2016 in London to discuss how life sciences companies are adopting new standards and best practices to comply with global compliance, legal, and transparency regulations. […]

0 comments

MMIS President and CEO Michaeline Daboul to speak at CBI’s 10th Annual Forum on Transparency & Aggregate Spend

Insight and Predictions: Shedding Light on the Future Use of Open Payments Data Washington, DC, August 15, 2016 – MMIS, Inc. creator of the award winning MediSpend Global Compliance Platform, announced today that MMIS President and CEO, Michaeline Daboul, will join legal and compliance professionals from CMS, EFPIA, Johnson & Johnson, and AstraZeneca at the […]

0 comments

MMIS to Sponsor 13th Annual Pharmaceutical Compliance Congress

Award Winning MediSpend® Global Compliance Platform to be Showcased at World’s Largest Compliance Event for the Bio/pharmaceutical Industry New York, NY, April 22, 2016 – MMIS, the company behind MediSpend® Global Compliance Platform, the leading global compliance and transparency solution for the life sciences industry, will be a sponsor at the 13th Annual Pharmaceutical Compliance […]

0 comments

MediSpend Recognized as Top Pharma and Life Sciences Technology Solution Provider for Second Consecutive Year

Company’s Global SaaS Compliance Platform Helps Customers Meet Transparency Requirements Through Innovation and Technology Leadership Portsmouth, NH, April 19, 2016 – MMIS, creator of the MediSpend Global Compliance Platform, the industry standard compliance and transparency solution for the life sciences industry, today announced it has been selected by CIOReview for its 2016 listing of the […]

0 comments

MMIS Partners with Healthcare Data Solutions to Deliver New, Cost-Effective Aggregate Spend Technology

MMIS and Healthcare Data Solutions (HDS) partner to bring a new spend tracking compliance solution paired with compliance-grade data specifically tailored to support small and medium-sized life sciences companies in complying with Open Payments requirements. Portsmouth, NH, March 17, 2015 – MMIS, creator of The MediSpend®Global Compliance Platform, the leading global compliance and transparency solution […]

0 comments

Open Payments: New Technology Solution Launched

Portsmouth, NH, November 5, 2014 – MMIS, creator of The MediSpend® Global Compliance Platform, the leading global compliance and transparency solution for the life sciences industry, today announced a new solution, MediSpend Federal to support small to mid-size companies in the life sciences industry.

Manufacturers who have hundreds instead of thousands of annual spend transactions, want a robust, rules-based federal reporting system that will produce all required federal Open Payments (Sunshine Act) reports. MediSpend Federal brings an affordable, easy to implement SaaS platform that validates and verifies HCPs and HCOs upon data import and ensures accurate and timely reporting for small to mid-sized life sciences companies.

0 comments

Highlights from First Open Payments Data Set

Yesterday, CMS made the first round of Open Payment data sets publically available on its website. The goal of collecting and making the information available is to help everyone understand the relationship between the healthcare industry (e.g., pharmaceutical and medical device manufactures) and healthcare providers (such as physicians and teaching hospitals). The data released represents […]

0 comments

Will the Open Payments public portal open today and will the data reveal the industry’s real relationships?

From a conversation with a representative from the Open Payments help desk last Friday, we learned that CMS intends to go live and make the public portal accessible today—Tuesday, September 30. That representative also recommended that people register at the CMS list serve in order to receive an email notification with details on how to […]

0 comments

MediSpend Alert: PhRMA Asks for CMS Transparency

August 26, 2014 Hot off the press from The Wall Street Journal comes a press release and statement from Pharmaceutical Research and Manufacturers of America (PhRMA) Assistant General Counsel, John Murphy. He noted that PhRMA member companies“ submitted their data in a manner consistent with the reporting rules outlined by the agency,” and he publicly […]

0 comments

MediSpend Alert: CMS Alters Data Matching Algorithm

August 21, 2014 Last Friday, The Centers for Medicare and Medicaid Services (CMS) announced modifications to previously provided matching algorithms requiring manufacturers to now match additional data elements in the NPPES or PECOS data sets. As a result of the CMS modifications to the matching algorithms, all manufacturers are experiencing the removal of previously submitted […]

0 comments

MMIS Offers its MediSpend Validate Tool for Free in Response to Industry Frustration with CMS Sudden Changes to Data Matching Algorithms

Portsmouth, NH August 22, 2014—MMIS, Inc., the leading provider of compliance solutions for pharmaceutical and medical device manufacturers, announces today that its MediSpend Validate tool will be available for free to manufacturers to help them validate their data against just-announced revisions to CMS’ Open Payments reporting requirements. MediSpend Validate allows organizations to upload Open Payments […]

0 comments

EDG Partners Invests in MMIS, Inc.

Portsmouth, NH August 13, 2014—MMIS, Inc., the creator of the MediSpend global compliance and transparency family of products, announced an investment by EDG Partners, a private equity firm. The investment will enable MMIS to enhance and expand its global offerings, increase sales and marketing activities, and add to its talented engineering, operations, marketing and sales […]

0 comments